Nasolabial Folds: Why Filler Isn’t Always the Answer

CHAPTER

01

WHAT ARENASOLABIALFOLDS, ANDWHY DO THEYDEEPEN?

A nasolabial fold is the crease that runs from the side of the nose to the corner of the mouth. Almost every adult face has one, including young faces, because it is where the mobile upper lip meets the relatively fixed cheek. It deepens because of changes beside it rather than inside it: the cheek above loses projection, the skin over it loses firmness, the fat beside it shifts, and expression repeats.

The fold is a boundary, not a defect. On one side of it, the upper lip moves freely with speech and expression. On the other side, the cheek is more tethered to the deeper structures of the face. The crease exists because two regions of the face move differently, and a face that could not make this boundary would not be able to smile.

That is why the fold is present in young faces. A twenty-five year old with visible nasolabial folds does not have a problem. They have anatomy. The fold is part of how the mouth and cheek are constructed, and in many people it is simply more visible than in others from the beginning.

What changes over time is not the fold itself but the structures around it. The cheek fat pads can deflate and shift downward, so the cheek mass sits lower than it once did. The skin loses some of its elasticity and firmness, so it creases more readily. The tissue beneath the cheek gradually descends. Repeated expression continues to mark the crease that was always there. Each of these changes makes an existing fold read as deeper, even where nothing about the crease itself has changed.

In some faces there is a different contributor: a naturally full cheek that overhangs the fold. Here the crease is not deepened by loss of support but by the volume resting above it. This distinction matters, because the two situations respond to opposite approaches. A face that has lost support may benefit from restoring it. A face with a full cheek sitting over the fold may look heavier, not better, with more volume.

It is also worth separating a shallow crease that appears only in expression from a fold that is visible at rest. An expression-only crease is a movement finding. A static fold is a structural one, and the two open different conversations. A static fold has depth that remains when the face is still, which usually means the structures around it have changed enough to hold the crease open.

One claim this study does not make is that smile lines are caused by smiling. Expression reveals the fold and maintains it; it does not create it. Smiling less will not remove it, and treating the muscles of expression is not the answer for a structural crease. Nor can a nasolabial fold be permanently removed. A fold is a feature of a moving face, and the realistic goal is a softer, better supported fold, not its disappearance.

THE LINEIS THESHADOW.THE CAUSEIS UPSTREAM.

CHAPTER

02

THESMILE LINEMAP.

The Smile Line Map is JOLA's editorial framework for reading a nasolabial fold. A visible crease may involve any of seven components: support, fat, skin, movement, descent, proportion and anatomy. Not every patient has all seven, not every component can be changed non-surgically, and not every component should be treated.

The first component is support. The midface and cheek sit above the fold, and when that structure loses projection, the crease beneath it is revealed by the shadow of the change rather than by the crease deepening. This is the most common reason a fold appears to worsen without anything happening to the fold.

The second is fat. The cheek fat compartments beside the fold can shift downward over time, changing where the cheek mass sits relative to the crease and to the mouth corner. Fat that has moved is not the same problem as skin that has lost firmness, and the two are frequently confused.

The third is skin. Firmness, elasticity and surface quality over the fold affect how sharply the crease reads. Thinner, less elastic skin creases differently from firm skin, and cumulative sun exposure changes the surface. This is a firmness conversation, not a volume conversation.

The fourth is movement. The lip elevators and the constant motion of speaking and smiling reveal and maintain the crease. Movement is not a flaw, and it is rarely the primary mechanism, but it shapes what a realistic result can look like.

The fifth is descent. Over years, soft tissue shifts position. When the change is significant, the honest conversation may involve surgical evaluation, because filler adds volume and does not reposition descended tissue.

The sixth is proportion. A fold that reads as prominent may be a relationship question involving the cheek, the lip, the chin or the overall balance of the face. Proportion is not a single-area problem, and treating one element of it changes the others.

The seventh is anatomy. Some faces have a visible fold at twenty-five and always will. That is structure, not aging, and the correct conversation may be no treatment at all.

Reading a fold means identifying which of these are present and which matter most. The map is not a menu. It is a way of deciding what the crease you see is actually made of, so that whatever follows is aimed at a mechanism rather than at a shadow.

ONEFOLD.SEVENPOSSIBLEINFLUENCES.

CHAPTER

03

WHY DOESCHEEK VOLUMEAFFECTSMILE LINES?

The fold often reads deeper when the structure above it loses projection. The cheek is the ceiling above the crease, and when midface support diminishes, the cheek mass sits lower and the fold beneath it is revealed as a shadow. Restoring midface support can soften the fold indirectly, without placing product in the fold at all.

The mechanism is support, not fill. A crease is visible because of the light and shadow around it. Raise the structure above the crease and the shadow changes, even though the crease itself has not been touched. This is why a face can look softer at the fold after a treatment that never went near it.

That said, this is not universal, and the exception matters as much as the rule. A face with a naturally full cheek that already overhangs the fold may look heavier rather than softer with additional midface volume. In that anatomy, the fold is not deepened by loss of support; it is deepened by the volume resting above it. Adding more makes the overhang worse.

The assessment therefore has to answer a specific question before any product is considered: has this cheek lost support, or is it already full? The two faces look similar in a photograph and require opposite approaches. This is the single most common place where a fold treatment goes wrong.

Where support loss is the mechanism, the conversation may involve filler placed in the midface for structural projection, or a biostimulator such as Sculptra for a gradual build of collagen and support over months. Where the cheek is already full, the conversation turns elsewhere, toward the skin, the surface, or toward no treatment at all.

It is worth saying plainly that filler placed in the fold does not support the midface, and midface support does not erase a fold. They are different interventions aimed at different components of the same appearance. A plan that confuses them will not do what the patient expected.

SUPPORTBEFOREFILL.

CHAPTER

04

CAN FILLERDIRECTLY IN THENASOLABIALFOLD WORK?

Yes, in selected faces. Conservative filler placed along the fold can soften a static crease, particularly when the midface is already well supported and the concern is primarily the crease itself. In many faces it is the wrong first step, because it treats the shadow rather than the cause.

When the midface has good projection, the skin has reasonable quality, and the fold is a defined static crease, a small amount of product along the fold can improve how it reads. The goal in that situation is subtle: softening the crease rather than eliminating it, and preserving the natural transition between the upper lip and the cheek.

The difficulty is that this region tolerates excess poorly. The nasolabial fold sits at one of the most closely read transitions in the face. Over-filling it flattens the transition between the lip and the cheek, which can produce a pillowed or heavy mid-face that reads as treated rather than refined. The fold is also a moving structure, so anything placed there is asked to hold a shape that expression works against all day.

There is a second reason fold filler is often the wrong first step: the fold may not be the finding that changed. If the cheek has lost support, adding product to the crease addresses the shadow while leaving the cause in place. The fold reads better in a photograph and no better in a mirror at eye level, because the structure above it is still lower than it was.

Anatomy adds a third consideration. The nasolabial region is vascular, and the vessels there matter. This is not a reason for alarm; it is a reason that injector experience and a thorough understanding of the local anatomy matter more here than in many other areas of the face. Product selection, placement and quantity are clinical decisions made at the consultation, not specifications that belong in an article.

None of this makes fold filler wrong. It makes it specific. In the right face, placed conservatively, it does something useful that nothing else does as directly. In the wrong face, it is the fastest way to make a fold look treated instead of reduced.

FILLINGTHE FOLDIS NOTSUPPORTINGTHE FACE.

CHAPTER

05

IS SCULPTRAA BETTEROPTION FORSMILE LINES?

Not better, different. Sculptra is a biostimulator used by clinicians for the midface and cheek region, where it works gradually over months to build collagen and structural support. It is not placed into the fold itself, and it is not an instant result. It suits a different problem: broader loss of volume and support rather than a single crease.

The distinction between a filler and a biostimulator is a distinction between two mechanisms. Filler adds volume at the moment it is placed. A biostimulator such as poly-L-lactic acid works with the skin's own collagen over time, so the change accumulates across weeks and months rather than appearing the same day. Neither is superior; they address different situations and different expectations.

For a nasolabial fold, the relevant question is whether the fold is being driven by a broader loss of midface support. Where it is, a gradual structural approach may fit the pattern of change better than a single area of volume placed on one day. Where the fold is a defined static crease in an otherwise well supported midface, a biostimulator is not aimed at the right target.

Candidacy is therefore about the mechanism, not the product. A patient who wants an immediate, visible change on the day of treatment is not a good fit for a biostimulatory approach, because that is not how it works. A patient whose primary concern is skin laxity rather than volume is also not a good fit, because biostimulation does not tighten skin. A patient with broader support loss who is comfortable with gradual change, and who wants the result to develop rather than arrive, may be well suited to it.

The treatment is typically discussed as a series rather than as a single appointment, and the result is assessed over time. That means the consultation has to set expectations clearly about what the first session will and will not look like, and about when the change is expected to be visible.

Sculptra is used by clinicians across a range of facial volume and support concerns, and the specific indications appropriate to any individual are confirmed at consultation. Where a patient is comparing a biostimulator with a conventional filler for the same area, that comparison is worth making directly, because the two approaches differ in timing, in number of sessions and in what the result feels like along the way.

SCULPTRAIS NOTA CREASEFILLER.

CHAPTER

06

DOES SKINTIGHTENING HELPNASOLABIALFOLDS?

Sometimes, and only for one component. When the fold is deepened by reduced skin firmness and mild tissue laxity, energy-based tightening may address the firmness component. At JOLA this includes XERF, a multifrequency radiofrequency platform. Tightening does not add volume, does not reposition significantly descended tissue, and does not fill a crease.

The mechanism here is different from filler in every respect. Radiofrequency delivers energy into tissue to produce a controlled heating response, which the skin answers over the following weeks and months with new collagen and a firmer quality. The change is progressive rather than immediate, and it is a change in the tissue rather than a change in the contour.

That makes it relevant to the fold in a specific way. Where the skin over and around the fold has lost firmness, tightening can improve how the crease reads by improving the quality of the skin. Where the fold is deepened by structural support loss or by a full overhanging cheek, tightening does not address the mechanism, and expecting it to remove the fold leads to disappointment.

The limits are worth stating plainly. Tightening does not add volume, so it does not replace a crease with fullness. It does not reposition tissue that has descended significantly, so it is not a substitute for surgical evaluation in an advanced case. It does not erase a static fold, because a static fold has depth.

Candidacy is assessed conceptually. A patient with reasonable skin quality and mild laxity is the profile where a firmness treatment is most likely to contribute. A patient with significant descent, or with a fold driven by volume loss, is likely better served by a different conversation. The assessment decides which of these applies, and device settings, treatment intervals and the number of sessions are clinical decisions made in person, not figures to be published in an article.

Where tightening and volume are both relevant, the sequence matters, and the two are not interchangeable. A plan that treats the skin and then reassesses the support is a different plan from one that adds volume first. Which order is right depends on the individual face.

SKINBEFOREVOLUME.

CHAPTER

07

CAN BOTOXTREATSMILE LINES?

Generally no. Nasolabial folds are mostly structural and gravitational rather than muscle-driven, so a neuromodulator is not aimed at the mechanism. Relaxing the muscles that lift the upper lip risks a flattened or asymmetric smile, which is a worse outcome than the fold.

It helps to be precise about what a neuromodulator does. It reduces the activity of the muscle it is placed into, which is why it works so well on expression lines created by a specific muscle pulling on skin. A nasolabial fold is not created that way. It is a crease formed by the boundary between two regions that move differently, revealed and deepened by changes in support, fat and skin.

The muscles near the fold lift the lip and shape the smile. Reducing their activity changes how the smile reads, and not usually for the better. A flattened or uneven smile is a recognisable consequence of treating the wrong target, and it is not a subtle one.

There is a narrow place where clinicians may consider a neuromodulator in relation to this region. In a small subset of faces, an expression-related finding near the upper lip may be judged to have a muscular component, and a clinician may consider a limited role for a neuromodulator as part of a broader plan. That use is off-label, it is a matter of clinical judgment, and it is not a primary treatment for nasolabial folds. It is not something a patient should request by name.

For most people asking about smile lines, the useful conclusion is that a neuromodulator is not the answer, and the conversation should move toward support, skin quality and assessment. Neuromodulators remain a valuable part of aesthetic planning elsewhere, which is precisely why they should not be pointed at a problem they do not solve.

A SMILE LINEIS NOTA SYMPTOMOF SMILING.

CHAPTER

08

WHAT ABOUTRESURFACINGAND SKINCARE?

Resurfacing and clinical skincare can improve the surface quality of the fold: the fine etched lines within it, the texture and the tone of the skin over it. They do not change structural depth. The fold is still a fold, and the skin over it can simply look better, which is a real result and a different one from reshaping the crease.

Resurfacing works on the surface layer of the skin, creating a controlled injury that the skin answers with renewal and new collagen. At JOLA this category includes fractional CO2 resurfacing with eCO2 3D and ULTRA fractional laser. Both improve texture, fine lines and tone over a course of healing. Neither is expected to change how deep a nasolabial fold is, because structural depth is not a surface property.

That said, the surface matters to how a fold reads. A crease surrounded by fine etched lines and uneven texture looks older than the same crease surrounded by smoother skin. Improving the surface around the fold changes the overall impression of that part of the face without changing the crease.

Clinical skincare is the slower, quieter version of the same idea. Consistent daily care supports the skin's quality over months, does not produce an immediate visible difference, and does not reshape anything. Positioned correctly, it is the foundation that everything else sits on rather than a treatment in its own right.

The correct framing for both is support, not solution. Resurfacing and skincare can make the skin over a fold better than it was. They cannot fill a crease, lift a cheek or reposition tissue. Where a plan includes them alongside support or tightening, each element is doing a different job, and the plan should say which job belongs to which.

SURFACEIS NOTSTRUCTURE.

CHAPTER

10

NASOLABIALFOLDS VSMARIONETTELINES: WHAT ISTHE DIFFERENCE?

Nasolabial folds run from the side of the nose to the corner of the mouth. Marionette lines run from the corner of the mouth down toward the chin. They are in different locations, involve different anatomy, and open different treatment conversations. They are frequently confused because both sit near the mouth.

A nasolabial fold is bounded by the nose above and the cheek outside it. A marionette line begins at the mouth corner and travels downward, separating the lower cheek from the chin. One is a boundary between the lip and the cheek. The other is a boundary between the cheek and the chin. They read differently in the mirror and they respond to different mechanisms.

The confusion is understandable, because a face that has begun to change in one area is often changing in the other. Tissue descent can affect both regions at once, and a patient looking at photographs may notice a single impression of overall change rather than two distinct lines. Separating them is part of what the assessment does.

For this study, the marionette line is out of scope. It is the subject of the next study in this series, and the honest position is that it deserves its own treatment rather than a paragraph here. Where a marionette line is present alongside a nasolabial fold, both are noted at consultation and each is addressed on its own terms.

What the two do share is a principle. Both are boundary creases, and in both cases the crease is usually the least informative thing about the problem. What matters is what has changed on either side of it. That principle carries across the lower face, and it is why this series treats one region at a time rather than offering a general answer.

DIFFERENTLOCATION.DIFFERENTCONVERSATION.

CHAPTER

11

WHO IS ACANDIDATE, ANDWHO IS NOT?

Candidates for non-surgical approaches generally have mild to moderate folds driven by a support change or a skin-quality change. Patients with significant tissue descent, a heavy overhanging cheek, or a long-standing deep static fold may be better served by a surgical conversation. Non-surgical treatment is not equivalent to a facelift.

A good candidate is identified by mechanism rather than by wanting a treatment. A fold that has deepened because the midface lost support, in a face with reasonable skin quality and only mild laxity, is the profile where a non-surgical plan has the most to offer. A fold that has deepened because of significant descent is a different situation, and it should be described as one.

Descent is the honest boundary. Filler adds volume and does not reposition descended tissue. Energy-based tightening improves the quality of skin and does not lift a face. Where tissue has moved significantly, non-surgical treatment can soften an impression but cannot restore position, and a patient whose primary goal is a change in position deserves to hear that clearly rather than to purchase a series that will not produce it.

The same honesty applies to a full cheek that overhangs the fold. This anatomy is not a candidate for more midface volume, and treating it as though it were is one of the more common ways a face is made to look heavier. Here the useful conversation is about the skin, the surface, and sometimes about restraint.

There is also a candidacy question that has nothing to do with anatomy. A patient whose fold is simply their structure, present since their twenties and unchanged, is not automatically a candidate for anything. A fold that has not changed is not a problem to be solved, and the most valuable outcome of that consultation may be clarity rather than treatment.

Where a non-surgical plan is appropriate, it is often staged. Support, skin and surface may each have a place, and they do not all need to happen at once. Where it is not appropriate, the plan is a referral, a later reassessment, or nothing at all, and each of those is a legitimate conclusion.

SOMETIMESTHE HONESTANSWERIS SURGERY.

CHAPTER

12

WHAT ARETHE RISKS?

Non-surgical fold treatment carries real, well-described risks. For injectable treatment these include bruising, swelling, asymmetry, lumps or irregularities, and an overfilled or heavy appearance. The nasolabial region also carries a recognised risk of vascular compromise, which is why injector expertise matters. For radiofrequency tightening, temporary redness and rarely burns or textural change are reported.

Bruising and swelling are the most common and the most transient. They relate to the vascularity of the region, which is higher around the mouth and nose than in many other areas of the face. Most settle within days, and the expected range should be described at consultation rather than discovered afterwards.

Asymmetry and irregularities are the risks most tied to technique and to quantity. Because the two sides of a face are rarely identical and the fold region is under constant movement, a result that is even and natural requires restraint. Over-correction in this area produces the heavy, pillowed mid-face that reads as treated, and it is difficult to disguise.

The most serious risk specific to this region is vascular. The nasolabial area is close to vessels that matter, and filler placed in or near them carries a recognised risk of vascular compromise, a condition in which blood supply to tissue is interrupted. This is a rare but serious event, and it is the reason that injector training, anatomical knowledge and the ability to recognise and manage a complication are not optional in this area.

Where a hyaluronic acid filler has been used, an antidote exists that can dissolve it. That is one reason hyaluronic acid products are often chosen in higher-risk regions. Biostimulators are not reversible in the same way, which is part of why the assessment and the discussion of expectations matter so much before they are used.

Tightening carries a different risk profile. Temporary redness and some swelling are common and short-lived. Burns and changes in skin texture are rare but described, and depend on device, settings and the individual's skin. Candidacy assessment, including skin type and history, is how those risks are managed.

No article can tell a patient their individual risk. That is a conversation held at consultation, where a clinician can consider the specific anatomy, history, medications, and the plan that is actually being proposed. What an article can do is name the risks honestly so that the conversation starts in the right place.

EXPERTISEIS PARTOF SAFETY.

CHAPTER

13

HOW LONG DORESULTS LAST,AND WHAT DOESMAINTENANCELOOK LIKE?

Longevity depends on the category of treatment rather than on a single number. Hyaluronic acid filler typically lasts months to over a year depending on the product and the individual. Biostimulators develop gradually and last longer. Tightening results are progressive and maintained over time. Skincare is ongoing by nature. Exact timelines are discussed at consultation.

For filler, the range is genuinely wide and varies with product, region, the individual's metabolism and the quantity used. A number quoted as a fact would be a number quoted for someone else. What matters is the shape of the maintenance: filler is generally revisited at intervals rather than replaced permanently.

Biostimulators behave differently. Because the change comes from the skin's own collagen response, it develops over months, and the result tends to be longer-lasting than a single filler placement. The trade is time. A patient expecting a change on the day will be disappointed by the mechanism itself, not by the treatment.

Tightening is progressive and cumulative. The tissue response develops over the weeks and months following treatment, and maintenance is generally a matter of reassessing rather than of scheduling by habit. The result is not an event with a defined end point so much as a change in tissue quality that is maintained.

Skincare does not have a duration in the same sense. It supports the skin continuously, and stopping means the support stops. It is neither a treatment with a result nor a maintenance interval; it is a background condition for everything else.

What maintenance should not be is a calendar. The right moment to reassess is when something has changed, or when the result has softened, or when a new concern has appeared. A plan built around how a specific face is actually aging tends to be smaller than a plan built around a schedule, and easier to sustain.

SOFTERIS NOTERASED.

CHAPTER

15

DOES AGEOR WEIGHTCHANGE THECONVERSATION?

Yes, at both ends. Folds in the twenties and thirties are frequently expression or natural anatomy and often need no treatment. In the forties and fifties, support and skin changes dominate. From the sixties onward, descent and the surgical boundary become more relevant. Significant weight loss, including GLP-1 related loss, can deepen folds through midface deflation.

In the twenties and thirties, a visible nasolabial fold is usually anatomy rather than change. The crease is where the lip meets the cheek, and in some faces it is simply more visible. Where it is a static fold that has been present since adolescence and has not deepened, the honest answer is often that nothing needs to be done. Where it is genuinely deepening, the assessment looks for a reason rather than reaching for a product.

In the forties and fifties, the picture usually shifts. Midface support begins to change, the cheek fat compartments move downward, and the skin over the fold loses some firmness. This is the decade where the distinction between support and surface becomes most useful, because more than one component is often in play at once, and treating only one leaves the appearance partly unchanged.

From the sixties onward, tissue descent becomes the more prominent variable, and the surgical conversation becomes more relevant rather than less. Non-surgical treatment can still contribute, particularly on skin quality and surface, but where position has changed significantly, a non-surgical plan should be described as what it is rather than as an alternative to something it cannot do.

Weight is the other variable, and it is under-discussed. Substantial weight loss reduces facial volume, and the midface is often where it shows first. A face that has lost volume in the cheek does not have a change in the fold, but the fold reads differently because the structure above it has deflated. A patient who has recently lost weight may be looking at a fold that deepened without anything happening to the fold.

This is particularly relevant to patients on GLP-1 medications, where weight loss can be rapid. Rapid loss does not give the skin time to adapt, and the midface can look deflated in a way that reads as both deeper folds and a flatter cheek. Understanding the timing matters, because a face in the middle of active weight change is often a face to reassess rather than to treat.

THECONVERSATIONCHANGES.THEANATOMYDOES NOT.

CHAPTER

16

WHAT DONASOLABIAL FOLDTREATMENTSCOST INDALLAS?

JOLA does not publish prices for fold treatment online, because cost is determined by the plan rather than by the area. The factors that shape it are the treatment category, the quantity of product where product is used, the number of areas addressed, whether the plan targets support or the crease itself, and the maintenance cadence over time.

The most useful way to think about cost here is by category rather than by line item. A support plan and a fold plan are different plans, with different quantities and different schedules, even if both are described by a patient as treating a smile line. A figure quoted before the assessment would be a figure for someone else's face.

Two specifics are worth naming. First, treating support is generally a different cost from treating the crease, and in many faces support is the part that produces most of the change. Second, a treatment series is not the same as a single appointment, and comparing the price of one session against a staged plan compares two different things.

At consultation, the plan is described before it is priced, and the reasoning behind each element is explained. That means the patient can decide what to include, what to defer and what to skip, with a clear understanding of what each step is for. A quote that does not explain what it is buying is not a quote worth accepting.

Where cost is the deciding factor, saying so directly is useful. A staged plan can often be spread across a longer period, and some elements can wait. What is not useful is reducing the number of areas treated in a way that leaves the mechanism unaddressed, which produces a result that costs less and does less.

A PRICEIS NOTA PLAN.